Companion Animal Health Market Research Report 2023, Industry Trends, Share, Size, Demand and Future Scope 2028

How Big is the Companion Animal Health Market ? :

IMARC Group’s latest report, titled “Companion Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global companion animal health market size reached US$ 23.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028.

What is Companion Animal Health ? :

Companion animal health refers to the medical care and well-being of pets, including dogs, cats, and other small animals, that serve as companions to humans. It encompasses various aspects of veterinary medicine, preventive healthcare, diagnostics, therapeutics, and overall management of pets' health conditions.

Companion animal health focuses on ensuring the longevity, quality of life, and emotional well-being of pets through regular check-ups, vaccinations, treatment of illnesses, and preventive measures such as parasite control and nutrition management.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/companion-animal-health-market/requestsample

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

• Agrolabo S.p.A
• Boehringer Ingelheim
• Ceva Santé Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• IDEXX Laboratories Inc
• Indian Immunologicals Limited (National Dairy Development Board)
• Merck & Co. Inc
• Norbrook Laboratories
• Vetoquinol SA
• Virbac 
• Zoetis 

Companion Animal Health Market Growth:

The global market is primarily driven by the increasing awareness regarding the importance of companion animals' emotional well-being. In line with this, the expanding pet population is resulting in the formation of a larger customer base for companion animal health products and services. Moreover, the increasing availability of sophisticated diagnostic tools, advanced surgical procedures, and specialized geriatric care for aging pet population are further creating a positive market outlook.

In addition to this, the development of advanced services and products, such as behavior therapy, stress reduction techniques, and enrichment activities is creating lucrative opportunities in the market. Furthermore, the increasing popularity of customized nutrition plans, supplements, and nutraceutical products tailored to address specific health conditions or support overall well-being of the animals are creating a positive market outlook.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/companion-animal-health-market

Key Market Segmentation:

Breakup by Animal Type:

• Dogs
• Cats
• Equine
• Others

Breakup by Product:

• Vaccines
• Pharmaceuticals
• Feed Additives
• Diagnostics
• Others 

Breakup by End User:

• Point-of-care Testing/In-house Testing
• Veterinary Hospitals and Clinics
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other) 

Key Highlights of the Report: 

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape 

Related Report by IMARC Group:

• https://www.imarcgroup.com/cyber-warfare-market
• https://www.imarcgroup.com/graphite-electrodes-market
• https://www.imarcgroup.com/hydration-belt-market
• https://www.imarcgroup.com/military-aircraft-modernization-retrofit-market
• https://www.imarcgroup.com/iot-connectivity-market

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800